Information

Back Number of 2026

• NEW
  16 Feb.

  Towa Receives Manufacturing and Marketing Approval for Generic Drugs

• NEW
  13 Feb.

  FY2025(3rd quarter) Supplementary Material of Financial Results

• NEW
  13 Feb.

  Consolidated Financial Results for the Nine Months Ended December 31, 2025(Based on Japanese GAAP)

• NEW
  21 Jan.

  Strategic collaboration between brand-name and generic drug companies Toward Ensuring a Stable Supply of Off-Patent Medicinal Products

• 5 Jan.

  Updated IR Calendar